MedTrace Logo

Continuous Glucose Monitoring for Women With Diabetes Mellitus in the Intrapartum and Postpartum Inpatient Care

NCT05492890 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-08-09

No results posted yet for this study

Summary

Diabetes mellitus affects roughly 8% of pregnancies and is associated with significant perinatal and maternal morbidity. Increasing numbers of women are either entering pregnancy with a continuous glucose monitor (CGM) or are initiating use during pregnancy, with data emerging suggesting improved outcomes among those using CGM. Since the introduction of CGM in the late 1990s, there has been slow acceptance of their validation and use in the inpatient setting. The investigators propose an observational prospective cohort study to analyze the correlation of CGM data with traditional capillary glucose readings in the intrapartum and postpartum settings.

Conditions

  • Diabetes, Gestational

Interventions

DEVICE

Dexcom G6

Continuous glucose monitoring

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Elizabeth Buschur, MD · tOSU Medical Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2023-08-31
Completion
2023-08-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05492890 on ClinicalTrials.gov